Medicare Enrolled
Dr. Talha Riaz, M.D.
Hematology & Oncology · Weatherford, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Riaz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Riaz?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Riaz
Dr. Talha Riaz is a hematology & oncology specialist in Weatherford, TX, with 12 years of NPI registration. Based on federal Medicare data, Dr. Riaz performed 195,234 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Riaz received a total of $3,772 from 50 pharmaceutical and/or device companies across 135 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Riaz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years of NPI registration
▲ Top 1% volume in TX
$3,772 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗195,234
Medicare services
Top 1% in TX for hematology & oncology
Not available
Unique patients (not deduplicated)
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
97,500 | $1 | $3 |
| Filgrastim injection (Nivestym) for white blood cells An injection of the biosimilar medication filgrastim-aafi (Nivestym) at a dose of 1 microgram. |
47,521 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 16,800 | $43 | $115 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
16,050 | $0 | $5 |
| Denosumab injection (Prolia/Xgeva) | 8,100 | $19 | $40 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,510 | $0 | $5 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,770 | $1 | $52 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
587 | $132 | $350 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
487 | $89 | $275 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
436 | $2 | $60 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
389 | $7 | $300 |
| Flow cytometry, additional marker An additional marker is tested during a flow cytometry procedure to analyze DNA or cells. This step adds specific data points to the initial analysis. |
371 | $19 | $125 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
358 | $22 | $100 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
344 | $96 | $412 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
333 | $12 | $70 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
268 | $11 | $60 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
261 | $47 | $190 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
168 | $48 | $202 |
| COVID-19 test, self-administered An FDA-approved, authorized, or cleared test kit for nonprescription self-administered and self-collected use. This code represents the provision of one test count. |
164 | $12 | $30 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
132 | $20 | $93 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
123 | $91 | $250 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
113 | $1 | $10 |
| New patient office visit, complex (60-74 min) | 81 | $154 | $500 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
75 | $47 | $160 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
48 | $46 | $401 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
46 | $165 | $681 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 41 | $106 | $450 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
40 | $1,155 | $4,069 |
| Additional 30 minutes of principal care management This service covers each additional 30 minutes of clinical staff time directed by a healthcare professional for managing a single high-risk disease, billed per calendar month. |
23 | $36 | $120 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
22 | $60 | $183 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
20 | $17 | $69 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
20 | $133 | $500 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
17 | $60 | $250 |
| Flow cytometry DNA or cell analysis, first marker A laboratory test that uses a laser to analyze cells or DNA by detecting a specific marker on the cell surface or within the cell. |
16 | $58 | $200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
50.5% high complexity
48.4% medium
1.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,772
Total received (2018-2024)
Avg $539/year across 7 years
Top 48% in TX for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
135
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$936
2023
$1,535
2022
$851
2021
$93
2020
$25
2019
$206
2018
$126
Payments by company (2024)
ABBVIE INC.
$178
Novartis Pharmaceuticals Corporation
$93
Merck Sharp & Dohme LLC
$92
BeiGene USA, Inc.
$84
E.R. Squibb & Sons, L.L.C.
$54
PFIZER INC.
$44
AstraZeneca Pharmaceuticals LP
$42
ADC Therapeutics America, Inc.
$33
GENZYME CORPORATION
$30
Tempus AI, Inc
$29
Apellis Pharmaceuticals, Inc.
$25
Astellas Pharma US Inc
$24
Blueprint Medicines Corporation
$24
Eisai Inc.
$23
ARRAY BIOPHARMA INC
$20
Incyte Corporation
$20
Daiichi Sankyo Inc.
$19
TerSera Therapeutics LLC
$19
SOBI, INC
$17
GlaxoSmithKline, LLC.
$17
Boehringer Ingelheim Pharmaceuticals, Inc.
$17
Janssen Biotech, Inc.
$17
Sirtex Medical Inc
$16
Top 3 companies account for 38.8% of 2024 payments
All-time payments by company (2018-2024) ›
Daiichi Sankyo Inc.
$553
Amgen Inc.
$250
ABBVIE INC.
$213
Novartis Pharmaceuticals Corporation
$211
Puma Biotechnology, Inc.
$176
Sirtex Medical Inc
$162
Rigel Pharmaceuticals, Inc.
$141
Celgene Corporation
$141
E.R. Squibb & Sons, L.L.C.
$124
Genentech USA, Inc.
$123
Stemline Therapeutics Inc.
$120
BeiGene USA, Inc.
$108
AstraZeneca Pharmaceuticals LP
$96
Merck Sharp & Dohme LLC
$92
PFIZER INC.
$90
Immunocore Limited
$72
Eisai Inc.
$67
Incyte Corporation
$57
Astellas Pharma US Inc
$56
GlaxoSmithKline, LLC.
$54
GENZYME CORPORATION
$50
Gilead Sciences, Inc.
$48
ADC Therapeutics America, Inc.
$48
Lilly USA, LLC
$45
Seagen Inc.
$43
Sun Pharmaceutical Industries Inc.
$42
Takeda Pharmaceuticals U.S.A., Inc.
$40
Janssen Biotech, Inc.
$37
SOBI, INC
$33
Epizyme, Inc.,
$32
PharmaEssentia USA Corporation
$31
Kite Pharma, Inc.
$30
Mirati Therapeutics, Inc.
$30
Tempus AI, Inc
$29
Pharmacyclics LLC, An AbbVie Company
$25
Apellis Pharmaceuticals, Inc.
$25
Regeneron Healthcare Solutions, Inc.
$25
Ipsen Biopharmaceuticals, Inc
$24
Blueprint Medicines Corporation
$24
EISAI INC.
$24
Genmab U.S., Inc.
$22
Acrotech Biopharma Inc.
$21
CTI BioPharma Corp.
$20
ARRAY BIOPHARMA INC
$20
Bayer HealthCare Pharmaceuticals Inc.
$20
TerSera Therapeutics LLC
$19
Boehringer Ingelheim Pharmaceuticals, Inc.
$17
Acrotech Biopharma LLC
$14
Pharmacyclics LLC, an AbbVie Company
$13
PUMA BIOTECHNOLOGY, INC.
$12
Top 3 companies account for 26.9% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AYVAKIT · Alecensa · Avastin · BAVENCIO · BELEODAQ · BESREMI · BLENREP · BRUKINSA · CALQUENCE · CYRAMZA · DOPTELET · Doptelet · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Empaveli · Enhertu · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · JAKAFI · JEMPERLI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LYNPARZA · Lenvima · MEKINIST · MONJUVI · NERLYNX · NINLARO · Nplate · OJJAARA · OPDIVO · OPDUALAG · Odomzo · Orserdu · PADCEV · PLUVICTO · PROMACTA · Pomalyst · REBLOZYL · RETEVMO · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SUTENT · Stivarga · TASIGNA · TAZVERIK · TECENTRIQ · TEVIMBRA · TUKYSA · Tavalisse · Tecentriq · Tivdak · Trodelvy · VENCLEXTA · Vonjo · Vyloy · XALKORI · XTANDI · Xtandi · YONSA · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
5
County median income
$102,099
Nearest hospital to ZIP centroid (approximate)
MEDICAL CITY WEATHERFORD
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Riaz is a mixed practice specialist, with above-average Medicare volume (top 1% in TX).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Riaz experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Riaz performed 97,500 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Riaz receive payments from pharmaceutical companies?
Yes. Dr. Riaz received a total of $3,772 from 50 companies across 135 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Riaz's costs compare to other hematology & oncology specialists in Weatherford?
Dr. Riaz's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Riaz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Weatherford
Browse hematology & oncology specialists in Weatherford ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology